| MCL-1 is a prognostic indicator and drug target in breast cancer KJ Campbell, S Dhayade, N Ferrari, AH Sims, E Johnson, SM Mason, ... Cell death & disease 9 (2), 19, 2018 | 202 | 2018 |
| Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer MJ McAllister, P McCall, A Dickson, MA Underwood, D Andersen, ... Prostate Cancer and Prostatic Diseases 23 (4), 596-606, 2020 | 12 | 2020 |
| Predictive biomarkers for endocrine therapy: retrospective study in tamoxifen and exemestane adjuvant multinational (TEAM) trial AK Roseweir, L Bennett, A Dickson, K Cheng, MA Quintayo, J Bayani, ... JNCI: Journal of the National Cancer Institute 110 (6), 616-627, 2018 | 11 | 2018 |
| Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1 C Beach, D MacLean, D Majorova, S Melemenidis, DK Nambiar, RK Kim, ... The Journal of clinical investigation 133 (23), 2024 | 9 | 2024 |
| IL-1β stimulates a novel, IKKα-dependent, NIK-independent activation of non-canonical NFκB signalling K McIntosh, YH Khalaf, R Craig, C West, A McCulloch, A Waghmare, ... Cellular Signalling 107, 110684, 2023 | 5 | 2023 |
| The relationship between oestrogen receptor‐alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer KKW Cheng, A Dickson, FJA Gujam, DC McMillan, J Edwards Histopathology 70 (5), 782-797, 2017 | 5 | 2017 |
| Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1 C Beach, D MacLean, D Majorova, S Melemenidis, DK Nambiar, RK Kim, ... The Journal of clinical investigation 134 (16), 2024 | 1 | 2024 |
| Radiation-induced changes in gene expression in rectal cancer specimens LVS Hillson, AK McCulloch, J Edwards, PD Dunne, SM O’Cathail, ... Clinical and Translational Oncology 26 (6), 1419-1428, 2024 | 1 | 2024 |
| Integration of mass-spectrometry-based global metabolomics and proteomics analysis to characterise different senescence induced molecular sub-phenotypes D Berardi, G Farrell, A Alsuntan, A McCulloch, Z Rattray, NJW Rattray bioRxiv, 2022.11. 30.518588, 2022 | 1 | 2022 |
| IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1 R Craig, K McIntosh, KH Ho, A McCulloch, C Riley, C Lawson, SP Mackay, ... Biochemical Pharmacology 232, 116736, 2025 | | 2025 |
| 665: Targeting C5aR1 to improve radiotherapy in tumours with immunosuppressive microenvironments C Beach, D MacLean, D Majorova, GN Valbuena, MD Damavandi, ... Radiotherapy and Oncology 194, S5200-S5201, 2024 | | 2024 |
| 2849: Exploring Biological Differences in Rectal Cancer Tumours Before Neoadjuvant Chemoradiotherapy LV Hillson, AK McCulloch, TS Maughan, J Edwards, PD Dunne, ... Radiotherapy and Oncology 194, S5433-S5435, 2024 | | 2024 |
| Assessing the role of JNK in human endothelial cell death induced by anti-cancer therapies A McCulloch | | 2024 |
| Pharmacological characterisation of a novel IL-1 beta-mediated early induction of noncanonical NF-kappa B signalling in human endothelial cells R Craig, R Plevin, K McIntosh, A McCulloch, C West, S Mackay, A Paul BRITISH JOURNAL OF PHARMACOLOGY 180 (4), 488-489, 2023 | | 2023 |
| Interleukin-1b stimulates a novel early activation of non-canonical NF Kappa B signalling pathway linked to CXCL12 production. K McIntosh, RG Craig, A McCulloch, S MacKay, A Paul, R Plevin British Pharmacology annual conference, 2022 | | 2022 |
| Il-1b Stimulates a Novel Axis within the Nfkb Pathway in Endothelial Cells Regulated by Ikka and Tak-1 R Craig, KA McIntosh, KH Ho, A McCulloch, SP Mackay, C Riley, ... | | |
